Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome Sciences Licenses Methylation Technologies to Qiagen

NEW YORK (GenomeWeb News) – OncoMethylome Sciences has inked a worldwide non-exclusive agreement granting Qiagen rights to use certain of its methylation technologies in future Qiagen products, the Liege, Belgium-based firm said today.
 
The firms anticipate that these future products will expand, among others, Qiagen’s EpiTect product line. Specifically, the agreement covers OncoMethylome Sciences’ methylation-specific PCR technology.
 
Qiagen will pay OncoMethylome Sciences an upfront fee plus royalties from future product sales utilizing the technology. Additional terms of the pact were not disclosed.
 
“MSP is a perfect match with our EpiTect product-line and allows us to further enable scientific progress in the development of diagnostics and therapeutics for cancer,” Achim Ribbe, executive director of corporate business development for Qiagen, said in a statement.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.